Emerging trends and global collaboration in Paclitaxel resistance research for breast cancer: a comprehensive bibliometric study.

ABSTRACT: Paclitaxel, a compound that targets microtubules in cancer cells and inhibits mitosis, has been used as a first-line treatment for recurrent or metastatic breast cancer for over three decades. Research into paclitaxel resistance has yielded thousands of articles. However, this body of research has not been analyzed systematically and quantitatively. This study employs bibliometric analysis and visualisation techniques using VOSviewer and CiteSpace software to elucidate the contributions from countries and institutions, collaboration patterns, journal publication trends, research evolution, and current hotspots. Our findings reveal that leading research institutions in the United States, Europe, and East Asia hold significant advantages in this field. Specifically, the United States contrib

SUBMITTER: Meng Y 

PROVIDER: S-EPMC12375520 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature